Here's what I find important about the new CRC con
Post# of 152323

It's about "Survival." So it's not about the nascent CRC trial. It must be the basket trial.
The basket trial aimed at 30 patients and 22 indications, so the number of CRC patients enrolled had to be very small.
I'm guessing there might have been 3-6 patients with CRC in that basket trial. And the ONLY result that would make this subsection of a tiny five-year-old trial newsworthy enough for a poster display now would have to be this:
MOST OR ALL OF THE CRC PATIENTS IN THE BASKET TRIAL FROM 2021 ARE STILL ALIVE, five years later.
Couple this with the five surviving NBC patients, and you have some amazing results. IMO.

